VDB
CVE-2026-112949
CVE-2026-112949
PUBLISHED
CVSS 4.7 MEDIUM
Reported by GitHub_M · Published October 20, 2026
Vitest is a Vite-native testing framework for JavaScript and TypeScript projects. From 2.1.0-beta.7 until 4.1.12 and 5.0.3, an unauthenticated non-browser WebSocket client that can reach a development server using interceptorPlugin can register a manual mock whose attacker-controlled url createManualModuleSource inserts unescaped into generated module source. When the developer browser loads the affected module, attacker-controlled JavaScript executes on the development-server origin. This issue is fixed in versions 4.1.12 and 5.0.3.
Risk Scores
CVSS 3.1
4.7
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:L/I:L/A:N
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| vitest-dev | vitest | >= 2.1.0-beta.7, < 4.1.12, >= 5.0.0, < 5.0.3 |
| @vitest | mocker | >= 2.1.0-beta.7, < 4.1.12, >= 5.0.0, < 5.0.3 |
| vitest | vitest | |
| wolfi | renovate | 0 |
| @vitest | mocker | 2.1.0-beta.7, 5.0.0 |
| vitest | mocker | 5.0.0-beta.1, 2.1.0-beta.7 |
| wolfi | vitess-24 | 0 |
| chainguard | langfuse-fips-4 | 0 |
| vitest-dev | vitest | 2.1.0-beta.7, 5.0.0 |
| chainguard | renovate | 0 |
| chainguard | langfuse-4 | 0 |
| chainguard | vitess-24 | 0 |
Timeline
- Oct 20, 2026 Coalition ESS Score
- Oct 20, 2026 CVE Published
- Oct 21, 2026 CVE Updated
- Oct 21, 2026 EPSS Score
- Oct 25, 2026 EPSS Score
- Oct 29, 2026 EPSS Score
- Oct 30, 2026 Security Advisory
References
- https://github.com/vitest-dev/vitest/security/advisories/GHSA-qxg6-89mg-rqv8 x_refsource_CONFIRM
- https://github.com/vitest-dev/vitest/commit/15cc006aa9f8683dc5f7e895d011fa7dc751ce35 x_refsource_MISC
- https://github.com/vitest-dev/vitest/commit/b825313243dc55757e8d7c0f9e7a792135e13473 x_refsource_MISC
- https://github.com/vitest-dev/vitest/releases/tag/v4.1.12 x_refsource_MISC
- https://github.com/vitest-dev/vitest/releases/tag/v5.0.3 x_refsource_MISC
- https://nvd.nist.gov/vuln/detail/CVE-2026-112949 advisory
- https://github.com/advisories/GHSA-qxg6-89mg-rqv8 advisory